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longed utilization and more efficient dialysis treatment.
Multiple methods are described for superficializing arte-
riovenous fistulas and minimizing the surgical interven-
tion is advantageous for patient recovery and potentially
improved outcomes. We describe a novel technique em-
ploying a minimally invasive technique, liposuction, with
the use of ultrasonography to ensure the safety of the
AVF.
Technical Description: After identifying the AVF
using B mode duplex, tumescent anesthesia was admin-
istered under ultrasound guidance between the fistula
and subcutaneous tissues. After a short period of time (5
minutes) is allowed for epinephrine induced vasocon-
striction to occur and a 2 mm aspiration cannula is then
inserted under ultrasound guidance. Continuous aspira-
tion on the syringe is performed with the cannula in
constant motion in a radial pattern above the arterio-
venous fistula under direct ultrasound guidance. This
direct ultrasound mapping and guidance minimizes po-
tential complications, such as injury to the fistula or
disruption of small tributary veins. This technique is
performed on the overlying adipose tissue until the
fistula was easily palpable and visible pulsations were
noted underneath the skin. After thinning the tissue, the
fistula was examined using B mode duplex to ensure no
injury, pseudoaneurysm, or extravasation and spectral
duplex to confirm adequate flow through the fistula.
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Objectives: Pseudoaneurysm (PSA) formation is a
complication of hemodialysis access. Open repair requires
PSA resection, interposition graft placement, and insertion
of a catheter as a bridge. Endovascular stent graft repair is
an alternative that permits immediate use of the access site.
The objective of this study was to determine the efficacy of
stent grafts for repair of arteriovenous fistula (AVF) and
graft (AVG) PSA.
Methods: A retrospective review of medical records
from October 2007 to December 2010 revealed 21 pa-
tients with a PSA who underwent endovascular repair using
a stent graft. Indications for repair included PSA with
symptoms (n 12), PSAwith skin erosion (n8), PSAwith
failed hemodialysis (n3), and PSA after balloon angio-
plasty of a stenosis (n1). Outcome measures were techni-
cal success, 30-day and 180-day patency, secondary inter-
ventions, and complications.
Results: Twenty-four self expanding stent grafts (Via-
bahn, WL Gore n22; Fluency, Bard n2) were used to
treat hemodialysis access (AVG n12, AVF n9) PSA in
21 patients (14 females, mean age55.3 yrs, mean
BMI28.3, mean PSA diameter 17.9 mm). Co-morbidi-
ties included hypertension (n19, 91.4%) and diabetes
mellitus (n8, 38.1%). The median time from access cre-
ation to repair was 455 days. The technical success rate was
100%. The 30 and 180 day patency rate was 100% and
69.2%, respectively. Two secondary interventions were per-
formed for treatment of unrelated stenosis. Treatment fail-
ure occurred in 5 (20.8%) stent grafts due to infection
(n3) and thrombosis (n2). Treatment of PSA with skin
erosion was associated with failure due to infection (OR
3.3, 95% CI 0.41, 26.34). The remaining 19 (79.2%) stent
grafts remain patent. The mean follow up time was 299
days (median 126).
Conclusions: Endovascular treatment of hemodialysis
access PSA using stent grafts is an effective and durable
option. PSA with skin erosion may increase the risk of
failure due to infection.
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Objectives: The effect of HRT for postmenopausal
women on peripheral atherosclerosis remains in question.
Our goal was to analyze the use of HRT in a large popula-
tion of postmenopausal women to determine its association
with the prevalence of PAD.
Methods: A prospective database of patients who
underwent vascular screening was used. Identification of
patients as postmenopausal, and their use of HRT was
based on questionnaires. PAD was noted if the ABI was
0.9.
Results: Analysis was performed on 847,982 postmeno-
pausal women; 433,178 (51.1%) reported having used HRT.
HRT patients were slightly older than patients who had not
used HRT (64.7 yrs vs. 64.3 yrs). HRT patients were signifi-
cantly more likely to be Caucasian (93.6% vs. 83.3%), to have
smoked cigarettes (42.8% vs. 40.6%), to have hypertension
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